BioPharma Column
BioPharma News
Technology Review Feed - Biomedicine Top Stories
Biospace news
MiddleBrook Pharmaceuticals, Inc. Plans Massive Layoffs, CEO Resigns
Pfizer Inc. Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Pfizer Inc. Says Sutent Breast Cancer Trials Fail
Sanofi-Aventis K.K. And Bristol-Myers Squibb Company Announce Important Updates to PLAVIX U.S. Prescribing Information; FDA Announces New Boxed Warning on Plavix
Roche Holding AG, Genentech (South SF)'s Avastin Fails in Prostate Cancer Study
Platelet-Rich Fibrin Matrix Shows No Impact On Clinical Outcomes, Study At American Academy of Orthopaedic Surgeons Conference Finds
Women On Pill 'May Live Longer', Aberdeen University Study
AVEO Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
FDA Approves Eisai Inc.'s Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)
Breast Cancer Drug Fulvestrant Appears More Effective in the Presence of CK8 and CK18, Indiana University Study
Novel Stroke Treatment Passes Safety Stage of Clinical Trial At University of California, Irvine Study
Movement Disorder Symptoms Are Lessened by an Antibiotic, University of Alabama at Birmingham Study
University of Essex Scientists Make Important Discovery in Gene Regulation
Ipsen Grants Obesity Treatment Licence; will Receive up to $80 Million
Genetix Pharmaceuticals, Inc. Secures $35 Million in Series B Funding
Arena Pharmaceuticals, Inc. will Launch Lorcaserin with Partner or Alone
University of Iowa Research Points to Way to Improve Heart Treatment
FDA Approves Watson Pharmaceuticals, Inc.'s TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
TaiGen Biotechnology Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints
Progenics Pharmaceuticals, Inc. to Advance Oral Methylnaltrexone into Late Stage Clinical Development
Calcium May Help You Live Longer, Karolinska Institute Study
Tumor Surgery Impairs Sexuality, Study in
Ligand Pharmaceuticals Inc. Announces Approval for GlaxoSmithKline's Revolade(R) in Europe
Azur Pharma Inc. to Acquire Elan Corporation PLC's Painkiller Prialt
AstraZeneca PLC Boosts Generic Exposure with Torrent Pharmaceuticals Ltd. Deal
Despite Law, Drug Safety Still A Concern At FDA
Portola Pharmaceuticals, Inc.'s Announces CEO, M.D. to Retire
Patient Safety Reporting and Drug Label Accuracy Missing Vital Information, Expert From Memorial Sloan-Kettering Cancer Center Says
200 Manchester Jobs Under Threat in AstraZeneca PLC Cuts
Drug-Resistant Lice Respond Better to Ivermectin, Study in The New England Journal of Medicine
Local Pharma Can And Should Step Up Outsourcing Play
Disease Cause Is Pinpointed With Genome, Baylor College of Medicine Study
Experimental Drug That Mimics Thryoid Hormone Safely Lowers 'Bad' Cholesterol, Johns Hopkins University School of Medicine Study
FDA Rules Out Thigh Fracture Link with Bisphosphonate, Including Medications such as Merck & Co., Inc.'s Fosamax
Hormone Thought to Slow Aging Associated With Increased Risk of Cancer Death, University of California, San Diego (UCSD) Study
Clark Johnson Appointed Neurologix, Inc. President and CEO
BioSante Pharmaceuticals, Inc. Says Leukemia Vaccine Shows Promise in Study
Senetek PLC Embarks on New Strategic Direction; Company Completes $3.0 Million Financing; CEO and CFO Terminated in Connection with Financing
Discovery of 'Fat' Taste Could Hold the Key to Reducing Obesity, Deakin University Study
Basilea Pharmaceutica: Johnson & Johnson Seeks Europe Rehearing on Skin Drug
Turning Tables On Prostate Cancer's Drug Resistance, University of California, San Diego (UCSD) Study
OXiGENE Announces $7.5 Million Financing
Beijing to Build Asia's Largest Pharmaceutical Base
Seaweed Extract May Hold Promise for Non-Hodgkin's Lymphoma Treatment, The Hashemite University Study
UCB Group: Newly-Published Study Reinforces Role of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) as an Add-on Treatment that Significantly Reduces Partial-onset Seizures in Adults with Epilepsy
University of Pittsburgh Medical Center Gets New Partners in Plan for Vaccine Factory
Merck & Co., Inc.'s Stromectol Wipes Out Hard-to-Treat Lice, Study Finds
Abbott Laboratories to Buy Facet Biotech for $722 Million
Amylin Pharmaceuticals, Inc., Eli Lilly and Company Diabetes Drug Faces Crucial FDA Decision
Novartis Corporation Takes Option on TRANSGENE Cancer Vaccine; Gets $10 Million, Milestones Could Reach $950 Million
Lacosamide Validated as Promising Therapy for Uncontrolled Partial-Onset Seizures, Barrow Neurological Institute, St. Joseph's Hospital, And Thomas Jefferson University Study
FDA Advisory Committee Recommends Approval of InterMune, Inc.'s Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
Exelixis, Inc. Announces Restructuring; Reduces Workforce by Approximately 40%, or 270 Employees
Skin Transplant Offers New Hope to Vitiligo Patients, Henry Ford Hospital Study
Cytokinetics, Inc.'s Lou Gehrig's Drug Gets Orphan Status
University of California, San Diego (UCSD) Study Shows Potential for Using Algae to Produce Human Therapeutic Proteins
Merck & Co., Inc.'s Fosamax: Is Long Term Use of Bone Strengthening Drug Linked to Fractures?
Watson Pharmaceuticals, Inc., Takeda Pharmaceutical Co. Ltd. Resolve Actos Patent Litigation
University of Missouri Researcher Presents Risk-free Treatment for Low Female Sexual Desire
Bristol-Myers Squibb Company CEO's 2009 Compensation Down 22%
Affymax, Inc. Receives $5 Million Milestone Payment from Takeda Pharmaceutical Co. Ltd. on Initiation of Phase 3 Clinical Trials for Hematide in Japan
University of Southern California Research Finds Shortcomings in Comparative Effectiveness Drug Research
Neuropharm Group plc to Mull Voluntary Liquidation to Return Cash
Oculus Innovative Sciences, Inc. Receives First FDA Clearance for Microcyn(R)-Based HydroGel for Dermatology Market
Transplant Drug Preserves Kidneys, Avoids Toxicity, Emory University Studies Suggest
Allergan Inc.'s BOTOX(R) (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults
Osteoporosis Drug Improves Healing After Rotator Cuff Surgery, Hospital for Special Surgery Study
Virus To Treat Prostate Cancer, Study
Obesity And Type 2 Diabetes Market Closely Linked But Vastly Different In Outlook
Ark Therapeutics Pulls Drug Application, Weighs Sale of Company
Back Researchers, Not Research, Say U.K. Science Advisers
Trading Halted Today in InterMune, Inc. Common Stock; FDA Advisory Committee Reviewing Pirfenidone Data in Idiopathic Pulmonary Fibrosis
New Ways to Disarm Deadly South American Hemorrhagic Fever Viruses, Howard Hughes Medical Institute Study
ECG Screening Found Cost-Effective In Kids With ADHD Considered For Stimulant Drugs, National Institutes of Health (NIH) Study
Cheers! A Drink a Day May Keep the Pounds Away, Brigham and Women's Hospital Study
University of Copenhagen Scientists Find Why "Sunshine" Vitamin D Is Crucial
AIDS Virus Can Hide In Bone Marrow, University of Michigan Study
AutoImmune, Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
BT PHARMA Secures USD 17.7 Million in Capital Funding and Changes its Name to Genticel
OSI Pharmaceuticals, Inc. Bid Likely to Rise as Astellas Pharma Inc. Seeks Cancer Sales
ISTA Pharmaceuticals, Inc. Receives PDUFA Action Date of October 16, 2010 for FDA Review of Once-Daily XiDay(TM)
Sanofi-Aventis (France), Merck & Co., Inc. to Create Animal Health Leader; to Pay $250 Million Plus $750 Million
Matrixx Initiatives, Inc. Says FDA Declines to Withdraw Warning Letter
New Method to Grow Arteries Could Lead to 'Biological Bypass' for Heart Disease, Yale University School Of Medicine Study
Bleeding Alert Sounded for Stroke Drugs, Rush University Medical Center Study
INSYS Therapeutics Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
XenoPort, Inc. Restructures to Focus on Key Programs; Includes An Overall Reduction of 50% of s Workforce
AstraZeneca PLC's Recentin Fails Phase 3 Trial, Hurts Shares
ExonHit Therapeutics Inc. and bioMerieux, Inc. Decide Not to Pursue Colon Cancer Program
Gene Site Discovered for a Children's Food Allergy, Study
Most Early-Stage Breast Cancer Patients May Not Need Radiation After Mastectomy, University of Texas MD Anderson Cancer Center Study
Repeated Anesthesia Can Affect Childrens Ability To Learn, Study
Eli Lilly and Company to Acquire European Rights to Pfizer Animal Health Assets
Roche Holding AG, Biogen Idec, Inc. (Massachusetts) Suspends Arthritis Treatment Ocrelizumab After Deaths
NicOx SA Announces FDA Advisory Committee to Discuss Naproxcinod on May 12; PDUFA Date Set for July 24, 2010
Genta Incorporated Announces $25 Million Financing
New Basis for Drug Development: Structure Determination of Biomolecules in Their Natural Environment, Helmholtz Zentrum Munchen Study
Nektar Therapeutics Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer
Snake Venom Charms Science World, Study in
Cell Therapeutics, Inc. Says FDA OKs Manufacturing Facility
Isis Pharmaceuticals, Inc. Earns $6 Million Milestone Payment From Bristol-Myers Squibb Company for BMS-PCSK9Rx
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by to Advance Epanova(TM), a Prescription Omega 3 Therapy
Two-Faced Testosterone Can Make You Nasty Or Nice, Stanford University Study
Pharma Layoff Stats Show the Glory Days of Drugs Won't Be Coming Back
Dutch Government Wants To Sell Flu Vaccines Back To Novartis AG And GlaxoSmithKline
Trial Launched to Test New Treatment for Pre-Invasive Breast Cancer, George Mason University Study
Dietary Supplements Discouraged For Prostate Cancer Patients, Study
New Strategy Develops Two Prototype Drugs Against Cancer, Retinal Diseases, University of Texas MD Anderson Cancer Center Study
Life Sciences Gets Push From Missouri Policymakers
In Case You Missed It: /A>'s EPI / NPAM 2010
FDA to Increase Criminal Prosecutions of Execs
The Pharmaceutical R&D Model is Broken. Here's How to Fix It
Effect of InterMune, Inc.'s Lung Drug, Pirfenidone Unclear; Shares Soar Despite FDA Concerns
Big Pharma Struggles To Benefit From Increased CVD Drug Usage
CSL Behring Receives FDA Approval of HizentraTM, First 20 Percent Subcutaneous Immunoglobulin Therapy
Hope For An Alzheimer's Breakthrough Remains Despite Pfizer Inc.'s Dimebon's Failure
Hope For An Alzheimer's Breakthrough Remains Despite Pfizer Inc.'s Dimebon's Failure
Putting Gene Duo To Work For Parkinson's, University of Sheffield Study
Scientists Identify New Drugs for Treating PTSD, University of Texas Study
Experimental Vaccine Protects Monkeys Against Mosquito-Borne Chikungunya Virus, University of Texas Study
Pfizer Inc. Cholesterol Flops Cleared Path for Resverlogix Corporation
Court Backs Five-Year Exclusivity for Shire plc's ADHD Drug Vyvanse
Merck & Co., Inc. Sues Teva Pharmaceutical Industries Limited to Block Generic Vytorin
Astellas Pharma Inc. Needs to Raise OSI Pharmaceuticals, Inc. Bid by 15%, OrbiMed Says
BIO.ORG video feed
BioPharma jobs
Jobs by Indeed
fiercebiotechresearch news
BioMaterial Column
BioMaterial News
Biomolecular Materials Group - Massachusetts Institute of Technology
AlgorithmWorks Network
BioFuels Column
Algae VS News & Events